Undaloc, Victoria V.

HRN: 01-91-78  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/22/2023
CEFTRIAXONE 1G (VIAL)
08/22/2023
08/29/2023
IV
2g
OD X 7 Days
UTI
Waiting Final Action 
08/22/2023
CEFTRIAXONE 1G (VIAL)
08/22/2023
08/28/2023
IV
2 G
Q12
For Sepsis
Waiting Final Action 
08/22/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/22/2023
08/28/2023
IV
500mg
Q8
T/c Acute Abdomen Sec To Ruptured Viscus, Sepsis
Waiting Final Action 
08/28/2023
AZITHROMYCIN 500MG TABLET (TAB)
08/28/2023
08/30/2023
PO
500mg
OD
Pneumonia
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: